Viewing Study NCT01082250


Ignite Creation Date: 2025-12-24 @ 4:45 PM
Ignite Modification Date: 2025-12-29 @ 5:30 PM
Study NCT ID: NCT01082250
Status: COMPLETED
Last Update Posted: 2011-09-08
First Post: 2010-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Bioequivalence Of Two Different Lurasidone Formulations In Patients
Sponsor: Sumitomo Pharma America, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module